All plans are billed upfront for three months following your introductory month
After TMB substrate solution is added, only those wells that contain Human CA19-9, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color
In late November, the Biden administration proposed a new rule to require Medicaid and Medicare programs to cover GLP-1s for weight loss
Takahashi H, Nomiyama T, Terawaki Y, Kawanami T, Hamaguchi Y, Tanaka T, Tanabe M, Bruemmer D, Yanase T
spin-out built around Hengrui-licensed incretin assets - IPO'd in 2025 with HRS-4729 as part of a portfolio anchored on HRS9531 (a dual GLP-1/GIP agonist that read out ~17.7% weight loss in Phase 3 in China in February 2026)